These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15952198)

  • 1. Hypoxia in head and neck cancer: how much, how important?
    Janssen HL; Haustermans KM; Balm AJ; Begg AC
    Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
    Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
    Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia in cancer: significance and impact on clinical outcome.
    Vaupel P; Mayer A
    Cancer Metastasis Rev; 2007 Jun; 26(2):225-39. PubMed ID: 17440684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours.
    Weinmann M; Belka C; Plasswilm L
    Onkologie; 2004 Feb; 27(1):83-90. PubMed ID: 15007254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study.
    Kyzas PA; Stefanou D; Batistatou A; Agnantis NJ
    Cancer Lett; 2005 Jul; 225(2):297-304. PubMed ID: 15978334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
    Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
    Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic sensitizer and cytotoxin for head and neck cancer.
    Lee DJ; Moini M; Giuliano J; Westra WH
    Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures.
    Gross J; Fuchs J; Machulik A; Jahnke V; Kietzmann T; Bockmühl U
    Int J Oncol; 2005 Sep; 27(3):807-14. PubMed ID: 16077932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypoxic tumor microenvironment and gene expression.
    Leo C; Giaccia AJ; Denko NC
    Semin Radiat Oncol; 2004 Jul; 14(3):207-14. PubMed ID: 15254863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1alpha in oral cancer.
    Brennan PA; Mackenzie N; Quintero M
    J Oral Pathol Med; 2005 Aug; 34(7):385-9. PubMed ID: 16011605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
    De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
    Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypoxia-inducible factor 1 and mechanisms of hypoxia signal transduction].
    Xu WL; Qian LJ; Zhang CG
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):169-70. PubMed ID: 12889157
    [No Abstract]   [Full Text] [Related]  

  • 16. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.
    Hoogsteen IJ; Marres HA; van der Kogel AJ; Kaanders JH
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):385-96. PubMed ID: 17433637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.
    Overgaard J
    Oncol Res; 1994; 6(10-11):509-18. PubMed ID: 7620219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies of hypoxia modification in radiotherapy.
    Kaanders JH; Bussink J; van der Kogel AJ
    Semin Radiat Oncol; 2004 Jul; 14(3):233-40. PubMed ID: 15254866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.